The Right RIA For You. All content copyrighted © 2019 – onwards by Ambastha Financial LLC.
By Kuldip K. Ambastha and Anil K. Ambastha On Friday, January 3, 2020, Tesla, Inc. (TSLA) delivered a gain of 3.0% closing at an all-time high of $443.01 per share due to positive news. Intra-day, the share price reached as high as $454.00 per share. Tesla beat Wall Street estimates for both car production and …
By Kuldip K. Ambastha and Anil K. Ambastha HAPPY HOLIDAYS, EVERYBODY! During this week of Christmas, Peloton Interactive, Inc. (PTON) and WW International, Inc. (formerly Weight Watchers International, Inc.) (WW) caught our eye. On Thursday, December 26, 2019 (the day after Christmas 2019), Peloton dropped by 6.1%, while WW International fell by 8.5%. Peloton is …
Continue reading “What Caught Our Attention in the Investment World? – Week of December 23-27, 2019”
By Kuldip K. Ambastha and Anil K. Ambastha On Monday, December 9, 2019, big news emerged in the mergers & acquisitions field in terms of Merck & Co., Inc. (MRK) buying ArQule, Inc. (ARQL) and Sanofi SA (SNY) buying Synthorx Inc. (THOR). Both Merck and Sanofi bought the smaller companies to enhance their capabilities in …
Continue reading “What Caught Our Attention in the Investment World? – Week of December 9-13, 2019”
By Kuldip K. Ambastha and Anil K. Ambastha Best Buy Co., Inc. (BBY), a big-box electronics retailer business headquartered in Richfield, MN, delivered strong results for 3Q2019. During the quarter, the company exceeded expectations on many fronts, such as earnings, revenues, and same-store sales. The key product and service lines which performed well were tablets, …
Continue reading “What Caught Our Attention in the Investment World? – Week of November 25-29, 2019”
By Kuldip K. Ambastha and Anil K. Ambastha Overstock.com, Inc. (OSTK) is an online retailer which offers a wide variety of products. Its stock fell by 17.4% on Tuesday, November 12, 2019 due to disappointing 3Q2019 results plus an investigation by the U.S. Securities and Exchange Commission (SEC). Specifically, a $0.89 loss per share was …
Continue reading “What Caught Our Attention in the Investment World? – Week of November 11-15, 2019”
By Kuldip K. Ambastha and Anil K. Ambastha Acadia Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company which has Nuplazid (aka: pimavanserin) in its product pipeline. Nuplazid has been used by individuals suffering from Parkinson’s disease-linked psychosis. Acadia has now analyzed Nuplazid in relation to individuals suffering from dementia-related psychosis. Currently, no approved drugs exist in …
Continue reading “What Caught Our Attention in the Investment World? – Week of September 9-13, 2019”